Kovitz Investment Group Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-26,761
Closed -$4.74M 415
2020
Q1
$4.74M Buy
26,761
+9,923
+59% +$1.87M 0.17% 96
2019
Q4
$3.22M Buy
16,838
+498
+3% +$89.8K 0.09% 151
2019
Q3
$2.75M Buy
16,340
+2,273
+16% +$370K 0.09% 164
2019
Q2
$2.35M Sell
14,067
-9,490
-40% -$1.31M 0.07% 182
2019
Q1
$3.45M Buy
23,557
+18,775
+393% +$2.72M 0.11% 143
2018
Q4
$639K Sell
4,782
-125
-3% -$20.5K 0.03% 217
2018
Q3
$935K Buy
4,907
+36
+0.7% +$6.61K 0.04% 97
2018
Q2
$812K Buy
4,871
+73
+2% +$11.7K 0.04% 100
2018
Q1
$807K Buy
4,798
+1,755
+58% +$294K 0.04% 96
2017
Q4
$498 Buy
+3,043
New +$546K 0.02% 116

Other funds holding AGN

Kovitz Investment Group Partners's AGN Position: Q2 2020 in Review

Kovitz Investment Group Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 26,761 shares — an estimated $4.74M sold.

Kovitz Investment Group Partners first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $4.74M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Kovitz Investment Group Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Kovitz Investment Group Partners sold 26,761 Allergan plc shares in Q2 2020, an estimated $4.74M.
  • Kovitz Investment Group Partners first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
  • Kovitz Investment Group Partners's Allergan plc position peaked at $4.74M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Kovitz Investment Group Partners's 13F filing for Q2 2020, filed 12 Aug 2020.